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Indications for Fine Needle Aspiration in Thyroid Nodules
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Thyroid nodules are a common clinical problem with the widespread use of ultrasonography. Fine needle aspiration (FNA) is the 
mainstay for diagnosing a thyroid malignancy. There have been several guidelines on when to perform FNA in thyroid nodules. 
This review is based on several published recommendations and helps physicians easily understand the factors favoring FNA.
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INTRODUCTION
With the increase in worldwide use of neck ultrasonography 
(US), the detection of thyroid nodules has rapidly increased to 
up to 67% of patients who undergo neck US [1]. Among them, 
only 4% to 7% of patients have palpable nodules on physical 
examination [2]. In South Korea, the yearly incidence has rap-
idly increased from 6.3 per 100,000 in 1999 to 47.5 per 100,000 
in 2009 [3].
 Fine needle aspiration (FNA) is the standard tool for detect-
ing thyroid cancer and has led to a decrease in the number of 
thyroid surgeries and an increase in cancer detected during 
thyroid surgery [4-6]. The overall incidence of thyroid cancer 
is about 9.2% to 13% in patients with thyroid nodules who un-
dergo FNA [7-9]. Also, the high detection rate of US makes 
FNA for all US-detected nodules impractical, if not impossi-
ble. Therefore, deciding which nodules should be biopsied is 
an important medical issue to ensure that no clinically signifi-
cant thyroid cancers are missed. There are several guidelines 
for the indications of FNA in thyroid nodules [10-14]. This 
work demonstrates these guidelines and compares their merits.
CONSIDERATION FACTORS TO PERFORM 
FNAs
Size
Thyroid nodule size itself is not a predictive factor of malig-
nancy [7,9-11]. Nevertheless, most guidelines recommend FNA 
for nodules larger than 10 mm [11,13,15], unless patients have 
high risk factors [15] or suspicious US features [13]. High risk 
factors include a history of thyroid cancer in one or more first-
degree relatives, a history of exposure to external beam radia-
tion or ionizing radiation in childhood or adolescence, prior 
hemithyroidectomy with discovery of thyroid cancer, fluoro-
deoxyglucose (18F) avidity on positron emission tomography 
scanning, multiple endocrine neoplasia (MEN) 2/familial 
medullary thyroid cancer-associated RET proto-oncogene mu-
tation, or calcitonin levels >100 pg/mL [15]. Based on the re-
vised American Thyroid Association (ATA) guidelines, FNA 
is recommended in thyroid nodules larger than 5 mm with 
suspicious US features in high risk patients. This guideline 
does not recommend FNA in thyroid nodules smaller than 5 
mm. The size criterion for FNA is slightly different between 
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the ATA and the American Association of Clinical Endocrinol-
ogists/Associazione Medici Endocrinologi (AACE/AME) 
guidelines. The AACE/AME guidelines suggests that FNA be 
performed regardless of lesion size when patients have a his-
tory of neck irradiation, a family history of medullary thyroid 
cancer or MEN2, extracapsular growth, or metastatic cervical 
lymph nodes [13]. The Korean Society of Thyroid Radiology 
(KSThR) has an even more strict size criteria [14]. They rec-
ommend FNA in thyroid nodules larger than 5 mm with suspi-
cious US features, even when a patient does not have high risk 
factors. They also recommend selective FNA in thyroid nod-
ules smaller than 5 mm according to risk factors and according 
to the performing radiologist’s experience.
 This diversity in size criteria stems from the uncertainty re-
garding the clinical meaning of early diagnosis for tiny thyroid 
cancers in patients at low risk. The rationale behind the recom-
mendations for FNA in larger nodules is based on a high rate 
of false positives and nondiagnostic cytology in thyroid nod-
ules smaller than 5 mm [16,17].
Number of nodules
Traditionally, single nodules are considered to be at more risk 
for malignancy than multiple nodules. However, patients with 
multiple thyroid nodules do not have a decreased likelihood of 
thyroid cancer when compared to patients with solitary nod-
ules [7,18]. The incidence of thyroid cancer in patients with 
multiple nodules is the same as that in patients with a solitary 
nodule, although the cancer rate per nodule decreases in pa-
tients with multiple nodules [19]. Thus, an FNA operator should 
focus on the US features of each individual nodule to decide 
whether or not to perform FNA.
Interval growth
Nodule growth is defined when a nodule shows more than a 
50% increase in volume or a 20% increase in at least two nod-
ule dimensions with a minimal increase of 2 mm in solid or in 
the solid portion of mixed nodules [15] in order to minimize 
interobserver bias of each measurement (Fig. 1) [20]. Although 
the growth itself is not a pathognomonic feature of malignancy 
[21] and the risk of malignancy is very low in a thyroid nodule 
Fig. 1. Ultrasonography (US) of growing benign mass in a 40-year-old woman who underwent fine needle aspiration twice. (A) Trans-
verse and (B) longitudinal US images demonstrate a 0.7-cm-sized isoechoic nodule with the cystic portion of the posterior portion of the 
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with benign cytology [13], repeated FNA is usually indicated 
in nodules that increase in size [14,15].
US features
Internal content of nodules
Depending on the components of the internal part of the thy-
roid nodule, nodules can be classified into cystic, mixed (both 
solid and cystic components), and solid nodules [22-24]. In 
cases where microcysts are aggregated in mixed nodules, the 
nodule is further defined as spongiform [25].
 An anechoic cyst is definitely benign and can contain hy-
perechoic spots with comet tail artifacts. The comet tail arti-
facts are related to microcrystals inside colloid cysts which 
should be differentiated from the microcalcifications of malig-
nant nodules.
 Solidity itself is not considered a suspicious US feature. How-
ever, several guidelines recommend FNA in solid nodules larg-
er than 10 mm and mixed echoic nodules larger than 15 mm 
with some variation in the defining size depending on the guide-
lines used [11,15].
Echogenicity
Traditionally, hypoechogenicity is a well-known US feature 
related to malignancy, and most thyroid carcinomas are hy-
poechoic compared with surrounding thyroid parenchyma 
[10,26,27]. Hypoechogenicity is a very sensitive sign of ma-
lignancy but is less specific than other features. Marked hy-
poechogenicity is defined as decreased echogenicity less than 
that of the adjacent strap muscle [10] and is a specific sign of 
thyroid cancer.
 The ATA and AACE/AME consider hypoechogenicity as a 
suspicious US feature [13,15]. In comparison, the KSThR con-
siders marked hypoechogenicity as a suspicious US feature [14].
Calcification
Microcalcification is a very specific US finding that suggests 
thyroid malignancy [11,13,15,22,24]. It is defined as a promi-
nent echogenic focus with or without posterior shadowing. 
Unlike other reports [11,13,15,22,24], the KSThR considers 
both microcalcification and macrocalcification as suspicious 
US features [14].
Margin
The analysis of nodule margins is very subjective, resulting in 
very low interobserver agreement [28-32]. Microlobulated, ir-
regular, infiltrative, or speculated margins have been consid-
ered as suspicious US features.
Shape
A taller than wide shape was first described by Kim et al. [10], 
after which it has been considered a suspicious US feature [13- 
15]. Although the ATA guidelines suggests that a taller than 
wide shape on transverse view alone is a suspicious US fea-
ture, a recent study demonstrates that a taller than wide shape 
in either the transverse or longitudinal plane can be accurate 
and sensitive for predicting thyroid malignancy [33].
Vascularity
Intranodular and chaotic vascularity have been considered as 
suspicious US features [13,15]. Recently, Moon et al. [34] 
published a study with color Doppler US performed on 1,083 
nodules and showed that there was actually more blood flow 
Fig. 2. Ultrasonography (US) of papillary thyroid cancer in a 60-year-old woman who underwent surgery. (A) Transverse and (B) longi-
tudinal US images demonstrate a 1-cm-sized hypoechoic taller than wide nodule with an irregular margin and internal microcalcifica-
tions in the right thyroid gland.
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distribution in benign nodules than in malignant nodules, and 
that vascularity was not helpful in differentiating benign and 
malignant nodules. The KSThR does not consider vascular 
pattern as a suspicious US feature [14].
Combinations of several suspicious US features
All of the US features explained thus far cannot alone diag-
nose thyroid nodules. The risk of malignancy increases as the 
number of suspicious US features increases (Fig. 2) [13,24].
CONCLUSIONS
Current guidelines vary on how to differentiate thyroid nod-
ules into benign or malignant nodules through US. Reported 
guidelines show substantial overlap in what defines benign 
and malignant nodules, and what might be considered benign 
by one recommendation might be considered malignant by 
another. Another issue is that US assessment is subjective and 
operator-dependent. Therefore, US performers should continu-
ously compare their readings with confirmed diagnostic results 
to maintain and improve proficient diagnostic abilities.
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